New Rotavirus Vaccine Effective In Early Trials
This article was originally published in PharmAsia News
A team of scientists from Australia and New Zealand said a rotavirus vaccine it has developed has been shown effective in early trials in protecting children five years of age and younger.
You may also be interested in...
The European Commission’s newly-published Pharmaceutical Strategy features a range of proposals related to generics and biosimilars, including “targeted policies” to improve competition, remove barriers and increase uptake.
Hospira’s efforts to circumvent two US patents shielding Par’s Adrenalin (epinephrine) have again ended in failure, following a ruling by the US Court of Appeals for the Federal Circuit.
New medicines under evaluation at the European Medicines Agency.